HCR — Health Issues
340B drug discount program; drug pricing; importation of biopharmaceuticals; direct-to-consumer (DTC) advertising; transparency; international pharmaceutical supply chain; PBM reform; TRICARE Pharmacy Program (FY2027 National Defense Authorization Act); Pandemic and All-Hazards Preparedness Act (PAHPA) reauthorization; S.891, Bipartisan Health Care Act; S.527, Prescription Pricing for the People Act of 2025; S.1040, Drug Competition Enhancement Act; S.1041, Affordable Prescriptions for Patients Act; S.1097, Interagency Patent Coordination and Improvement Act of 2025; S.1095, Stop STALLING Act; S.1096, Preserve Access to Affordable Generics and Biosimilars Act; Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients; FY2027 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; FY2027 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations.
- JASON BENJAMIN VAN PELT
- HUNTER MOORHEAD
- MATHEW LAPINSKI
- MARC NUMEDAHL
- JOHN GREEN
- SALIM ALAMEDDIN
- BRITTANY JOHNSON HERNANDEZ
- ms CHERYL LYNN JAEGER
- mr STEPHEN THOMAS VOLJAVEC
- WALLY BURNETT — covered position: Clerk, Senate Appropriations Committee [new]
Government entities lobbied: HOUSE OF REPRESENTATIVES; SENATE